82 results
Page 3 of 5
424B5
of4p7we1766cybt
11 Feb 22
Prospectus supplement for primary offering
5:28pm
6-K
EX-99.1
pnlsvw
5 Oct 21
VBL Therapeutics Announces Appointment of Sam Backenroth as Chief Financial Officer and Establishes Operations in the United States
4:17pm
6-K
EX-99.2
xthd380oh1 6e
2 Sep 21
Notice of Annual General Meeting of Shareholders
7:20am
6-K
EX-99.1
atto8oex
8 Jul 21
VBL Therapeutics Appoints Alison Finger and Michael Rice to its Board of Directors
4:05pm
POS AM
m4ui6hfwmsmj124
19 Apr 21
Prospectus update (post-effective amendment)
5:17pm
424B8
v4bi44 x9
19 Apr 21
Prospectus unintentially filed late
5:06pm
424B5
2hw7 mmwf4f
12 Apr 21
Prospectus supplement for primary offering
9:07am
424B5
q904x8hz0t2sj9z
9 Apr 21
Prospectus supplement for primary offering
12:00am
424B5
ebgrj
15 Jan 21
Prospectus supplement for primary offering
7:00am
424B3
xyo4p skomi
16 Nov 20
Prospectus supplement
7:15am
6-K
tur79dba
16 Nov 20
Current report (foreign)
7:00am
6-K
EX-99.2
5atfgp2yk667jo
19 Oct 20
Current report (foreign)
4:10pm
6-K
EX-99.1
dsoci89kcou730 zakd8
13 Oct 20
VBL Therapeutics Announces Appointment of Marc Kozin as Vice Chairman of Board of Directors
8:30am
424B3
y1o4tay z2twa8z7j
26 Aug 20
Prospectus supplement
5:21pm
6-K
s6z1b m72
13 Aug 20
Current report (foreign)
7:00am
F-1
ofa0vwdz6k04sf8
1 Jun 20
Registration statement (foreign)
12:18pm
6-K
EX-99.2
ezmmt50gfdv
28 May 20
Notice of Annual General Meeting of Shareholders
9:14am
6-K
t09d 8lkjvp42
14 May 20
Current report (foreign)
7:25am
424B5
pc7k11dy
12 May 20
Prospectus supplement for primary offering
12:02pm